CGT Summit 2026: Where Innovation, Science & Collaboration Converge in Cell and Gene Therapy
CGT Summit 2026: Advancing the Future of Cell & Gene Therapy
Boston, MA | July 6–8, 2026
The 3rd Global Cell & Gene Therapy Summit (CGT Summit 2026) brought together researchers, clinicians, industry professionals, biotechnology leaders, pharmaceutical experts, and innovators to explore the latest developments shaping the future of cell and gene therapy.
Key Highlights
3-Day International Conference
A focused three-day program featuring scientific presentations, keynote sessions, panel discussions, workshops, poster presentations, and networking opportunities. 
Global Participation
The summit brought together professionals and organizations from across the global cell and gene therapy community.
Scientific & Clinical Innovation
Discussions covered emerging technologies, translational research, clinical development, and the advancement of next-generation cell and gene therapies.
Cell & Gene Therapy Development
Experts shared insights into innovative approaches for developing safer, more effective, and scalable advanced therapies.
Viral Vector & AAV Technologies
Sessions explored advances in viral vector development, AAV manufacturing, quality, productivity, and analytical strategies.
Manufacturing & Process Development
Industry leaders discussed challenges and opportunities related to scalability, process optimization, quality, and commercial manufacturing.
Regulatory & Quality Strategies
Speakers highlighted the importance of regulatory planning, CMC, analytical development, quality control, and product consistency.
Commercialization & Market Access
Panel discussions examined how innovative therapies can move from scientific discovery toward commercially viable and accessible treatments.
Industry Collaboration
The summit provided opportunities for researchers, pharmaceutical companies, biotechnology organizations, manufacturers, investors, and service providers to connect and exchange ideas.
Networking & Knowledge Exchange
Participants engaged through networking sessions, poster presentations, exhibitions, and discussions, creating opportunities for new collaborations and partnerships.
Sponsors & Exhibitors
We extend our sincere appreciation to all the sponsors and exhibitors of CGT Summit 2026 for their valuable support and contribution to the success of the summit.
Their participation helped create an engaging platform for showcasing innovative technologies, services, solutions, and expertise across the cell and gene therapy ecosystem.
Our Sponsors & Exhibitors
Supporting Sponsor
Minaris
Exhibitors
- PathoQuest
- Smithers
- Novogen
- QIAGEN
- Foxx Life Sciences
We are grateful to all our sponsors and exhibitors for supporting CGT Summit 2026 and for contributing to meaningful conversations, collaborations, and connections throughout the three-day event.
Conclusion
CGT Summit 2026 brought together the global cell and gene therapy community to share knowledge, explore emerging innovations, and build meaningful collaborations. The discussions in Boston highlighted the importance of connecting scientific innovation, clinical development, manufacturing, regulation, and commercialization to advance next-generation therapies.
As the field continues to evolve, collaboration and knowledge exchange will remain essential to turning promising discoveries into impactful therapies for patients.
Thank you to all our speakers, delegates, sponsors, exhibitors, partners, and participants for making CGT Summit 2026 a successful and memorable event.
